Address
Robert-Rössle-Str. 10
Building C87, Berlin
Berlin
13125, Germany
Contact
Wolfgang Fecke+493094892420
wolfgang.fecke@eu-openscreen.eu
Website
Discovery of novel antibiotics
Product or Service High throughput screening and lead discovery
A large network of 17 experienced screening centres, including two institutes with focus on infectious diseases.
Technology:
Microorganisms:
Application:
Development stage:
- Antimicrobial compound/strategy
- Infection prevention
- Antimicrobial stewardship
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Viruses
- Fungi
- Parasites
- Yeasts
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Research
- Development
- Validation
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Academia
- Company
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Joint Venture
- Outsource
- Sell
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- STI
- BSI
- RTI
- GII
- SSTI
- CNSI
- IAI
- SSI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Embargo period of up to three years before screening data become open access. EU-OPENSCREEN works with full cost model and claims no IPR.
European research infrastructure consortium (ERIC) for chemical biology
Access to commercial and proprietary compound collections, medicinal chemistry expertise at 6 sites. Co-development of novel screening technologies.
